Collateral damage of COVID-19 pandemic on oncology clinical trials
Author(s) -
Sri Harsha Tella,
Anuhya Kommalapati,
Steve R. Alberts,
Robert R. McWilliams,
Amit Mahipal
Publication year - 2020
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco-20-200
Subject(s) - medicine , covid-19 , pandemic , collateral damage , coronavirus infections , clinical trial , betacoronavirus , intensive care medicine , virology , outbreak , disease , infectious disease (medical specialty) , criminology , sociology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom